Intelligent Respiratory Disorder Treatment System

A comprehensive system integrating AI, IoT, blockchain, and novel materials to provide personalized respiratory disorder treatment, ensuring optimal patient interface size and therapy settings.

The original patent, 'Mask sizing tool using a mobile application', addresses the limitation of manual patient interface size selection, which can lead to ineffective treatment. The new inventive concept builds upon this foundation by incorporating synergistic technologies to create a more powerful and efficient system.

The system comprises an RPT device, a patient interface, and a mobile application integrating AI to predict optimal patient interface size based on facial feature analysis. The system utilizes a blockchain-based secure data storage system to store patient facial feature data and employs an IoT-enabled RPT device to receive the selected patient interface size and adjust therapy settings accordingly. Additionally, the system incorporates a novel material-based humidifier integrated with a machine learning algorithm to optimize humidification settings based on real-time patient data. The mobile application provides a user interface to input patient facial feature data, securely stores the data using blockchain technology, and utilizes an AI-powered algorithm to predict optimal patient interface size and provide personalized therapy recommendations.

The new claims introduce the synergistic combination of AI, IoT, blockchain, and novel materials, which provides a non-obvious and innovative solution for personalized respiratory disorder treatment. The integration of these technologies enables real-time data analysis, secure data storage, and optimized therapy settings, thereby overcoming the limitations of the original patent.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT-enabled devices, or alternative blockchain-based secure data storage systems. Additionally, the system could be adapted for use in other medical fields, such as sleep apnea or chronic obstructive pulmonary disease (COPD) treatment.

The Intelligent Respiratory Disorder Treatment System has significant commercial potential in the respiratory disorder treatment market, particularly in the areas of sleep apnea and COPD. The system's ability to provide personalized therapy recommendations and optimize therapy settings could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.